Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001209191-16-147149

Options or other derivatives

  • Director acquired 135,612 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Reynolds Donald Rogers Director 2016-10-25 Grant or award · Stock Option (Right to Buy) +135,612 135,612 D
Loading xslF345X03/doc4.xml…